IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Medical Records
  • Volume:5 Issue:3
  • Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse

Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse

Authors : Zeynep Tuğba GÜVEN, Serhat ÇELİK, Bülent ESER, Mustafa ÇETİN, Ali ÜNAL, Leylagül KAYNAR
Pages : 455-9
Doi:10.37990/medr.1259944
View : 91 | Download : 102
Publication Date : 2023-09-18
Article Type : Research Paper
Abstract :Aim: It is known that the prognosis of acute leukemia patients who relapse after the first allogeneic stem cell transplantation insert ignore into journalissuearticles values(ASCT); is dismal. Our goal was to assess the value of a second allogeneic stem cell transplant in acute leukemia patients who experienced post-transplant recurrence. Material and Methods: We retrospectively reviewed data from 29 patients with relapsing acute leukemia who underwent a second ASCT. Nineteen patients with acute myeloid leukemia and ten patients with acute lymphoblastic leukemia were included in the study. Results: Ten AML patients and 10 ALL patients were included in the study. Most patients insert ignore into journalissuearticles values(62%); were in remission before the second transplantation. The median time between the first and second ASCT was 11.9 months insert ignore into journalissuearticles values(3.1-42 months);. Complete remission insert ignore into journalissuearticles values(CR); was achieved after the second ASCT in 21 insert ignore into journalissuearticles values(72%); patients, and 11 insert ignore into journalissuearticles values(52%); patients relapsed after the second ASCT. During this analysis, six patients insert ignore into journalissuearticles values(21%); were alive and in remission. Relapse of the disease was the leading cause of mortality. After the second ASCT, overall survival insert ignore into journalissuearticles values(OS); was 6.34 months, and leukemia-free survival insert ignore into journalissuearticles values(LFS); was 13.8 months. Conclusion: For patients with acute leukemia who relapsed after the first ASCT, a second ASCT is a good option and can keep patients alive.
Keywords : Post transplantation relapse, second transplantation, acute leukemia

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026